AORT.NYSEArtivion, INC

Form 4: Artivion VP Rochelle L. Maney Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Rochelle L. Maney, VP of Quality at Artivion, Inc., reports acquisition and disposal of common stock related to performance stock units.

Summary

  • On February 23, 2024, Rochelle L. Maney acquired 3,366 shares of Artivion common stock related to performance stock units granted on February 22, 2023.
  • Also on February 23, 2024, Maney acquired 6,418 shares of Artivion common stock related to performance stock units granted on February 22, 2023.
  • On February 26, 2024, Maney sold 1,185 shares at $20.2711 per share to cover tax withholding obligations.
  • On February 26, 2024, Maney sold 1,130 shares at $20.2711 per share to cover tax withholding obligations.
  • Following these transactions, Maney directly owns 44,485 shares of Artivion common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions related to compensation and tax obligations.

Positives

  • The vesting of performance stock units indicates that performance targets were likely met.

Future Outlook

Remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

Industry Context

Form 4 filings are a routine part of the regulatory landscape, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation mechanisms.

Key Dates

DateDescription
02/22/2023Date of grant for performance stock units.
02/23/2024Date of acquisition of shares from performance stock units.
02/26/2024Date of sale of shares to cover tax obligations.
02/22/2025Date of next potential vesting of 25% of remaining shares from Feb 2023 grant.
02/22/2026Date of final potential vesting of 25% of remaining shares from Feb 2023 grant.
02/28/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.